Critical Pressure is a startup based in the United Kingdom, most recent round Series A.
Critical Pressure is a company headquartered in the United Kingdom. Its most recent tracked round is Series A.
Critical Pressure is a biopharmaceutical company developing drugs to treat vascular dysfunction and shock, with an initial focus on severe sepsis, using technology that aims to avoid harmful effects associated with excess fluid administration.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.